Repare Therapeutics Inc. - Common shares, no par value (RPTX)

CUSIP: 760273102

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / Common shares, no par value
Shares outstanding
42,837,925
Total 13F shares
33,203,752
Share change
-235,597
Total reported value
$326,704,500
Put/Call ratio
19%
Price per share
$9.84
Number of holders
77
Value change
-$3,869,255
Number of buys
27
Number of sells
35

Quarterly Holders Quick Answers

What is CUSIP 760273102?
CUSIP 760273102 identifies RPTX - Repare Therapeutics Inc. - Common shares, no par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Repare Therapeutics Inc. - Common shares, no par value (RPTX) as of Q1 2023

As of 31 Mar 2023, Repare Therapeutics Inc. - Common shares, no par value (RPTX) was held by 77 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 33,203,752 shares. The largest 10 holders included BVF INC/IL, ORBIMED ADVISORS LLC, CHI Advisors LLC, ARK Investment Management LLC, Deep Track Capital, LP, Redmile Group, LLC, MPM ASSET MANAGEMENT LLC, T. Rowe Price Investment Management, Inc., BIOIMPACT CAPITAL LLC, and FMR LLC. This page lists 77 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.